Status: retired, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2470232013 | Co-prenozide 160mg/250mcg m/r tablet | en | Synonym | Active | Case sensitive | SNOMED CT core |
2572069019 | Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet (product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
2576042017 | Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
2579359019 | Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Is a | Cyclopenthiazide- and oxprenolol-containing product | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Is a | Co-prenozide tablet | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Has active ingredient | Diuretic | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Has active ingredient | Oxprenolol | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Is a | Cyclopenthiazide- and oxprenolol-containing product | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Has active ingredient | Cyclopenthiazide | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet | Has manufactured dose form | Modified-release oral tablet | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set